Testing effectiveness (Phase 2)Study completedNCT03418480
What this trial is testing
HARE-40: HPV Anti-CD40 RNA vaccinE
Who this might be right for
Human Papilloma Virus Related CarcinomaHead and Neck NeoplasmCervical Neoplasm+2 more
University of Southampton 32